Edwards Lifesciences files Form 144 for 150,758 units

Edwards Lifesciences files a Form 144 reporting a proposed sale of common stock.

Rhea-AI Filing Summary

Edwards Lifesciences files a Form 144 reporting a proposed sale of common stock. The filing lists 150,758.00 (units shown) associated with Charles Schwab & Co., Inc. on 05/18/2026 with method noted as Broker Payment for Cashless Exercise. The filing also records four completed sales in the prior three months: 87,004, 82,523, 84,585 and 85,576 (dated 03/11/2026, 04/06/2026, 05/01/2026, and 05/04/2026 respectively).

Insights

Securities Counsel

Form 144 lists a proposed brokerage sale following a cashless exercise.

Form 144 is a statutory notice of a proposed sale by an affiliate. The entry shows 150,758.00 units tied to Charles Schwab & Co., Inc. on 05/18/2026 and identifies the method as Broker Payment for Cashless Exercise.

Prior completed sales are documented with dates and unit counts; cash‑flow treatment and whether these are shares or other units are as stated in the excerpt. Subsequent filings or trade confirmations will show execution details.

Key Figures

Proposed units listed: 150,758.00 Prior sale 1: 87,004 Prior sale 2: 82,523 +2 more

5 metrics

Proposed units listed 150,758.00 Charles Schwab & Co., Inc. entry on 05/18/2026

Prior sale 1 87,004 Sale dated 03/11/2026

Prior sale 2 82,523 Sale dated 04/06/2026

Prior sale 3 84,585 Sale dated 05/01/2026

Prior sale 4 85,576 Sale dated 05/04/2026

Key Terms

Form 144, Cashless Exercise, Broker Payment

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Cashless Exercise financial

"Broker Payment for Cashless Exercise"

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

Broker Payment financial

"Broker Payment for Cashless Exercise"

FAQ

What does Edwards Lifesciences' Form 144 report?

The Form 144 reports a proposed sale of common stock and lists 150,758.00 units tied to Charles Schwab & Co., Inc. on 05/18/2026. It also records four sales in the prior three months with their dates and unit counts.

Does the filing show how the sale will be effected for EW?

Yes. The excerpt identifies the method as Broker Payment for Cashless Exercise for the 05/18/2026 entry, indicating the broker handles a cashless exercise mechanism according to the reported line item.

What prior sales are disclosed in the Form 144 for EW?

The filing lists four completed sales: 87,004 on 03/11/2026, 82,523 on 04/06/2026, 84,585 on 05/01/2026, and 85,576 on 05/04/2026. Each is shown with date and unit count.

Who is the broker or nominee listed in the Form 144?

The excerpt lists Charles Schwab & Co., Inc. with an associated figure of 150,758.00 and the exchange noted as NYSE for the 05/18/2026 line item. The entry names the broker and the method used.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 04:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002004380
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Edwards Lifesciences Corp
SEC File Number	001-15525
Address of Issuer	ONE EDWARDS WAY IRVINE CALIFORNIA 92614
Phone	9492502500
Name of Person for Whose Account the Securities are To Be Sold	Lippis Daniel J.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	1858	150758.00	575800000	05/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/18/2026	Employee Stock Option Exercise - See Remarks	EDWARDS LIFESCIENCES CORPORATION			1858	05/18/2026	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Daniel J. Lippis ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	03/11/2026	1019	87004.00
Daniel J. Lippis ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	04/06/2026	1019	82523.00
Daniel J. Lippis ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	05/01/2026	1019	84585.00
Daniel J. Lippis ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	05/04/2026	1019	85576.00

144: Remarks and Signature

Remarks	The options on this filing may be sold over various dates.
Date of Notice	05/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Daniel J. Lippis
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)